Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy…

By J. Eikelboom, L. Wallentin, Stuart J. Connolly, M. Ezekowitz, Jeff S. Healey, Jonas Oldgren, Sean Yang, M. Alings, Scott Kaatz, S. Hohnloser and 6 more. Circulation, 2011

1,187 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Neurology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/2ded01500e2c64febfe572e77139ceb2bfc0b939

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. G. Fonarow
2. T. Horwich
3. J. Januzzi
4. C. Yancy
5. M. Drazner
6. Véronique L. Roger
7. M. Gheorghiade

Citations in the corpus

• Dabigatran versus warfarin in patients with mechanical heart valves. (2013, neutral): “Death, stroke, systemic embolism, or myocardial infarction 11 (8) 2 (3) 2 (6) 0 13 (8) 2 (2) 3.”
• 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “Page 44 a lack of social support is associated with higher hospitalization rates (372, 373) _ENREF_3 and mortality risk”